| Outcome Measures: |
Primary: Change in Glycated haemoglobin (HbA1c ), percent-points, From baseline (week 0) to End of Study visit (V3) (week 34-44) | Secondary: Relative change in body weight, percent, From baseline (week 0) to End of Study visit (V3) (week 34-44)|Absolute change in body weight, Kilogram (Kg), From baseline (week 0) to End of Study visit (V3) (week 34-44)|HbA1c below 7 percent, Yes or No, End of Study visit (V3) (week 34-44)|HbA1c reduction greater than or equal to 1 percent-points and body weight reduction of greater than or equal to 5 percent, Yes or No, From baseline (week 0) to End of Study visit (V3) (week 34-44)|HbA1c reduction greater than or equal to 1 percent-points and body weight reduction of greater than or equal to 3 percent, Yes or No, From baseline (week 0) to End of Study visit (V3) (week 34-44)|DTSQc, (Diabetes Treatment Satisfaction Questionnaire, change) relative treatment satisfaction, Total score, End of Study visit (V3) (week 34-44)|DTSQs, (Diabetes Treatment Satisfaction Questionnaire, status) change in absolute treatment satisfaction, Total score, From baseline (week 0) to End of Study visit (V3) (week 34-44)
|
